BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 20834098)

  • 21. A multi-center open study to determine the effect of lamivudine on HBV DNA clearance and to assess the safety of the regimen in patients with chronic hepatitis B infection.
    Mazur W; Król F; Cianciara J; Nazzal K; Gładysz A; Juszczyk J; Bolewska B; Adamek J; Czajka B; Swietek K; Kryczka W; Gonciarz Z
    Med Sci Monit; 2002 Apr; 8(4):CR257-62. PubMed ID: 11951067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Synthesis of a novel L-nucleoside, beta-L-D4A and its inhibition on the replication of hepatitis B virus in vitro].
    Wu JM; Lin JS; Xie N; Qiu GF; Hu XM
    Yao Xue Xue Bao; 2005 Sep; 40(9):825-9. PubMed ID: 16342685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiviral effect of Curcuma longa Linn extract against hepatitis B virus replication.
    Kim HJ; Yoo HS; Kim JC; Park CS; Choi MS; Kim M; Choi H; Min JS; Kim YS; Yoon SW; Ahn JK
    J Ethnopharmacol; 2009 Jul; 124(2):189-96. PubMed ID: 19409970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of immunosuppressive and antiviral agents on hepatitis B virus replication in vitro.
    McMillan JS; Shaw T; Angus PW; Locarnini SA
    Hepatology; 1995 Jul; 22(1):36-43. PubMed ID: 7601429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alpha interferon-induced antiviral response noncytolytically reduces replication defective adenovirus DNA in MDBK cells.
    Guo JT; Zhou T; Guo H; Block TM
    Antiviral Res; 2007 Dec; 76(3):232-40. PubMed ID: 17897730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The short hairpin RNA driven by polymerase II suppresses both wild-type and lamivudine-resistant hepatitis B virus strains.
    Ren GL; Fang Y; Ma HH; Lei YF; Wang D; Xu MC; Wang PZ; Huang CX; Nie OH; Sun YT; Bai XF
    Antivir Ther; 2007; 12(6):865-76. PubMed ID: 17926641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human MxA protein participates to the interferon-related inhibition of hepatitis B virus replication in female transgenic mice.
    Peltekian C; Gordien E; Garreau F; Meas-Yedid V; Soussan P; Willams V; Chaix ML; Olivo-Marin JC; Bréchot C; Kremsdorf D
    J Hepatol; 2005 Dec; 43(6):965-72. PubMed ID: 16168514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The present state of research in direct antiviral mechanism of interferon on hepatitis B virus].
    Liu F; Tang H
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2009 Dec; 26(6):1358-62, 1371. PubMed ID: 20095503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Study on inhibitory effect of CpG-ODN on HBV replication in vitro].
    Li N; Fan XG; Chen ZH; Zhu C
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Jan; 21(1):103-5. PubMed ID: 15629096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, biological evaluation and structure-activity relationships of glycyrrhetinic acid derivatives as novel anti-hepatitis B virus agents.
    Wang LJ; Geng CA; Ma YB; Huang XY; Luo J; Chen H; Zhang XM; Chen JJ
    Bioorg Med Chem Lett; 2012 May; 22(10):3473-9. PubMed ID: 22520261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. APOBEC and iNOS are not the main intracellular effectors of IFN-gamma-mediated inactivation of Hepatitis B virus replication.
    Proto S; Taylor JA; Chokshi S; Navaratnam N; Naoumov NV
    Antiviral Res; 2008 Jun; 78(3):260-7. PubMed ID: 18313151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor necrosis factor-alpha and interferon-gamma inhibit synergistically viral replication in hepatitis B virus-replicating cells.
    Kawanishi Y; Hayashi N; Katayama K; Ueda K; Takehara T; Miyoshi E; Mita E; Kasahara A; Fusamoto H; Kamada T
    J Med Virol; 1995 Nov; 47(3):272-7. PubMed ID: 8551280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice.
    Kimura K; Kakimi K; Wieland S; Guidotti LG; Chisari FV
    J Virol; 2002 Nov; 76(21):10702-7. PubMed ID: 12368312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-cytolytic inhibition of hepatitis B virus replication in human hepatocytes.
    Suri D; Schilling R; Lopes AR; Mullerova I; Colucci G; Williams R; Naoumov NV
    J Hepatol; 2001 Dec; 35(6):790-7. PubMed ID: 11738107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The replication cycle of hepatitis B virus.
    Urban S; Schulze A; Dandri M; Petersen J
    J Hepatol; 2010 Feb; 52(2):282-4. PubMed ID: 20056291
    [No Abstract]   [Full Text] [Related]  

  • 36. Synthesis of Janus type nucleoside analogues and their preliminary bioactivity.
    Yang HZ; Pan MY; Jiang DW; He Y
    Org Biomol Chem; 2011 Mar; 9(5):1516-22. PubMed ID: 21225056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Searching for interferon-induced genes that inhibit hepatitis B virus replication in transgenic mouse hepatocytes.
    Wieland SF; Vega RG; Müller R; Evans CF; Hilbush B; Guidotti LG; Sutcliffe JG; Schultz PG; Chisari FV
    J Virol; 2003 Jan; 77(2):1227-36. PubMed ID: 12502840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of hepatitis B virus replication by interferon requires proteasome activity.
    Robek MD; Wieland SF; Chisari FV
    J Virol; 2002 Apr; 76(7):3570-4. PubMed ID: 11884582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Expression of porcine interferon-gamma and its safe antiviral assay].
    He F; Sun Y; Ge J; Li M; Chang T; Bu Z; Qiu H
    Sheng Wu Gong Cheng Xue Bao; 2010 Apr; 26(4):439-47. PubMed ID: 20575430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Genome structure, viral replication and morphologic formation of hepatitis B virus].
    Ueda T
    Uirusu; 1990 Jun; 40(1):30. PubMed ID: 2288067
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.